Medtronic (MDT) FCF Payout Ratio (2014 - 2026)

Medtronic (MDT) posted FCF Payout Ratio of 0.44 for Q2 2026, up 9.95% sequentially from 0.4 in Q1 2026, and little changed YoY from 0.43 in Q2 2025.

Medtronic (MDT) FCF Payout Ratio (2014 - 2026) Analysis & Trends

Medtronic has reported FCF Payout Ratio for 13 years, with the latest figure at 0.44 in Q2 2026.

Quarterly FCF Payout Ratio changed 0.45% year-over-year to 0.44 in Q2 2026, while the trailing twelve-month figure through Apr 2026 was 0.67 (down 3.11% YoY) and the FY2026 annual result came in at 0.67, down 3.11% from the prior year.
FCF Payout Ratio advanced to 0.44 in Q2 2026 per MDT's latest filing, from 0.4 in the prior quarter.
Over five years, FCF Payout Ratio peaked at 4.59 in Q4 2023 and troughed at 0.39 in Q2 2024.
A 5-year average of 1.16 and a median of 0.62 in 2022 frame the typical range for FCF Payout Ratio.
The sharpest annual moves came in 2023 and 2024: FCF Payout Ratio soared 204.14% in 2023, then plunged 64.72% in 2024.
Over 5 years, FCF Payout Ratio stood at 1.51 in 2022, then jumped by 204.14% to 4.59 in 2023, then slumped by 64.72% to 1.62 in 2024, then increased by 22.98% to 1.99 in 2025, then plunged by 78.13% to 0.44 in 2026.
According to Business Quant data, FCF Payout Ratio over the past three periods registered 0.44, 0.4, and 1.99 for Q2 2026, Q1 2026, and Q4 2025 respectively.

#	Company	Market Cap	Enterprise Value	Gross Profit (Qtr)	FCF Cover (Qtr)
1	Abbott Laboratories	198.70 Bn	193.10 Bn	7.27 Bn	0.55
2	Stryker	125.85 Bn	122.37 Bn	4.50 Bn	0.32
3	Medtronic	118.44 Bn	109.22 Bn	6.41 Bn	0.44
4	Boston Scientific	72.64 Bn	72.10 Bn	3.85 Bn	-
5	Edwards Lifesciences	51.94 Bn	47.69 Bn	1.35 Bn	-
6	Dexcom	34.48 Bn	32.53 Bn	830.00 Mn	-
7	GE HealthCare Technologies	33.60 Bn	31.49 Bn	2.18 Bn	0.24
8	Koninklijke Philips	26.30 Bn	22.98 Bn	4.55 Bn	-0.73
9	Steris	23.00 Bn	22.52 Bn	684.20 Mn	0.22
10	Zimmer Biomet Holdings	19.04 Bn	18.63 Bn	1.54 Bn	0.12

Download Data